Please select the option that best describes you:
Topics:
Radiation Oncology • Genitourinary Cancers
What are the current thoughts for ADT and prostate SBRT for low-Intermediate risk patients?
What number of cores and what % cores involved do you look at to consider them low-intermediate risk for prostate SBRT?
Answer from: Radiation Oncologist at Community Practice
Although I have no strong bias regarding ADT for low-intermediate-risk prostate cancer patients receiving SBRT, the growing volume of retrospective data in the same setting with HDR brachytherapy suggests that ADT is not needed. With HDR (either monotherapy or boost), I do not use ADT for intermedia...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Its hard to argue for ADT + SBRT in "low-intermediate" risk (do you mean "favorable-intermediate"???) when this same cohort of patients has evidence supporting active surveillance and/or behavior like low-risk patients. Just to be clear, I am using the MSKCC definition of no primary Gleason patter...